Zobrazeno 1 - 2
of 2
pro vyhledávání: '"CARES trial, The Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities"'
Autor:
Ahmad, Al-Abdouh, Safi U, Khan, Mahmoud, Barbarawi, Sireesha, Upadhrasta, Srajum, Munira, Anas, Bizanti, Hadi, Elias, Asadulla, Jat, Di, Zhao, Erin D, Michos
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective To investigate the association between using febuxostat and cardiovascular events. Methods Systematic search of randomized controlled trials was performed using PubMed/MEDLINE, Cochrane review, and EMBASE databases through April 17, 2019. M
Autor:
Al-Abdouh A; Department of Medicine, Saint Agnes Hospital, Baltimore, MD., Khan SU; Department of Medicine, West Virginia University, Morgantown, WV., Barbarawi M; Department of Medicine, Hurley Medical Center, Flint, MI., Upadhrasta S; Department of Medicine, Saint Agnes Hospital, Baltimore, MD., Munira S; Department of Medicine, Saint Agnes Hospital, Baltimore, MD., Bizanti A; Department of Medicine, Saint Agnes Hospital, Baltimore, MD., Elias H; Department of Medicine, Saint Agnes Hospital, Baltimore, MD., Jat A; Department of Medicine, Saint Agnes Hospital, Baltimore, MD., Zhao D; The Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins University, Baltimore, MD., Michos ED; The Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD.; Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins University, Baltimore, MD.
Publikováno v:
Mayo Clinic proceedings. Innovations, quality & outcomes [Mayo Clin Proc Innov Qual Outcomes] 2020 Aug 05; Vol. 4 (4), pp. 434-442. Date of Electronic Publication: 2020 Aug 05 (Print Publication: 2020).